Potential Impact of the 70-gene Signature in the Choice of Adjuvant Systemic Treatment for ER Positive, HER2 Negative Tumors: a Single Institution Experience

PUBLICATION: Breast. 2013 Aug;22(4):419-24. doi: 10.1016/j.breast.2013.03.013. Epub 2013 May 3. AUTHORS: Torrisi Read More

2013-08-01T21:52:25-07:00August 1st, 2013|Clinical Validation, Evidence, MammaPrint, The Breast, Torrisi|

Additional Value of the 70-gene Signature and Levels of ER and PR for the Prediction of Outcome in Tamoxifen-Treated, ER-Positive Breast Cancer

PUBLICATION: The Breast. 2012 Dec;21(6):769-78. doi: 10.1016/j.breast.2012.04.010. Epub 2012 Jun 26. Read More

2012-12-01T19:05:18-08:00December 1st, 2012|Clinical Validation, Evidence, Kok, MammaPrint, The Breast|
Go to Top